Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel treatment options for autoimmune diseases reported by AstraZeneca

July 29, 2008

Recent patents disclose novel antiinflammatory agents

July 29, 2008

New adenosine A2B receptor antagonists from Almirall

July 28, 2008

Novel HIV reverse transcriptase inhibitors named in recent Tibotec patent

July 28, 2008

Novel treatment options for obesity described in recent patents

July 28, 2008

New oncolytic agents imparted in recent patents

July 25, 2008

New agents for treating psychiatric disorders reported in recent AstraZeneca and Abbott patents

July 25, 2008

Recent Bayer Schering Pharma patents disclose novel contraceptive agents

July 25, 2008

Recent patents describe new agents for endocrine-related disorders

July 24, 2008

New compounds for neurological disorders disclosed in recent patents

July 24, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...